Moscow, June, 18 2006 Quantum and Federal State Institution “Scientific Research Institute of Pulmonology of Roszdrav” entered COPD collaboration.
Quantum and Federal State Institution “Scientific Research Institute of Pulmonology of Roszdrav» announced drug discovery collaboration. The collaboration is aimed on the application of Quantum’ proprietary drug discovery technology to identify novel small molecules inhibitors of Human Neutrophil Elastase.
Under the terms of agreement Institute will be responsible for biological evaluation and further development of discovered inhibitors.
About Quantumю.
Quantum is a drug discovery company based in Moscow, Russia specializing in small molecule screening and design through the use of its proprietary technology platform.
Related posts:
- Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.
- HIV-1 integrase drug discovery collaboration
- Quantum enters collaboration with Children’s Cancer Institute Australia
- Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.
- Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.
